Presented by AI Research & Bio.
ADME, TOX, Aaff, HTS, QM, Yields, Epitope, ADP, CRISPR, DTI, PPI, DrugRes, DrugSyn, MTI, Catalyst, MolGen, Reaction, ...
Absorption, Distribution, Metabolism, Excretion
Caco-2 (Cell Effective Permeability), Wang et al. PAMPA Permeability, NCATS HIA (Human Intestinal Absorption), Hou et al. Pgp (P-glycoprotein) Inhibition, Broccatelli et al. Bioavailability, Ma et al. Lipophilicity, AstraZeneca Solubility, AqSolDB Hydration Free Energy, FreeSolv
CYP P450 2C19 Inhibition, Veith et al. CYP P450 2D6 Inhibition, Veith et al. CYP P450 3A4 Inhibition, Veith et al. CYP P450 1A2 Inhibition, Veith et al. CYP P450 2C9 Inhibition, Veith et al. CYP2C9 Substrate, Carbon-Mangels et al. CYP2D6 Substrate, Carbon-Mangels et al. CYP3A4 Substrate, Carbon-Mangels et al.
Half Life, Obach et al. Clearance, AstraZenecat
Acute Toxicity LD50 hERG blockers hERG Central hERG Karim et al. Ames Mutagenicity DILI (Drug Induced Liver Injury) Skin Reaction Carcinogens Tox21 ToxCast ClinTox
SARS-CoV-2 In Vitro, Touret et al. SARS-CoV-2 3CL Protease, Diamond. HIV Butkiewicz et al.
QM7b, QM8, QM9
Buchwald-Hartwig USPTO
IEDB, Jespersen et al. PDB, Jespersen et al.
TAP SAbDab, Chen et al.
TAP SAbDab, Chen et al.
BindingDB DAVIS KIBA
DrugBank Multi-Typed DDI TWOSIDES Polypharmacy Side Effects
HuRI
DisGeNET
GDSC1 GDSC2
OncoPolyPharmacology DrugComb
MHC Class I, IEDB-IMGT, Nielsen et al. MHC Class II, IEDB, Jensen et al.
SAbDab
miRTarBase
USPTO
Trial Outcome Prediction (TOP)
MOSES ZINC ChEMBL
USPTO-50K USPTO
USPTO
PDBBind DUD-E scPDB